Armando Anido, Chairman & Chief Executive Officer at Zynerba Pharmaceuticals, Inc. (ZYNE), bought 5,000 shares at $19.76 ($99K) on 2017-05-12, disclosed to the SEC on 2017-05-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.76 | 3,500 | $69K | 70.2% |
| 2 | $19.57 | 1,500 | $29K | 29.8% |
| Total | $19.70 avg | 5,000 | $99K | 100% |
| Filing → |
| ZYNE | SELL | 2022-07-20 | $13K | — | Filing → |
| SCYX | BUY | 2020-12-23 | $31K | — | Filing → |
| ZYNE | BUY | 2018-08-07 | $89K | — | Filing → |